lirugen measles virus vaccine
dow corning new zealand limited - measles vaccine - solution for injection - active: measles vaccine
rouvax measles vaccine
seqirus (nz) ltd - measles vaccine 1000 tcid50 - suspension for injection - 1000 tcid50 - active: measles vaccine 1000 tcid50 excipient: alanine arginine hydrochloride asparagine aspartic acid cysteine cysteine hydrochloride monohydrate dextran 70 glutamic acid glycine histidine isoleucine leucine lysine hydrochloride methionine neomycin sulfate phenolsulfonphthalein phenylalanine proline serine sorbitol threonine tryptophan tyrosine urea valine water for injection
priorix - powder and solvent for solution for injection live attenuated measles-mumps-rubella vaccin
nm pharma limited 3/4, cantrija complex triq it-targa, il-maghtab naxxar nxr 6613 , malta - powder and solvent for solution for injection - measles virus - schwarz strain 50 % mumps virus jeryl lynn (level b) strain (live, attenuated) 50 % rubella virus - wistar ra27/3 strain 50 % - vaccines
priorix
glaxosmithkline australia pty ltd - measles virus, quantity: 1000 ccid50; rubella virus, quantity: 1000 ccid50; mumps virus, quantity: 25119 ccid50; live varicella vaccine, quantity: 1995 pfu - diluent, not applicable - excipient ingredients: water for injections - priorix-tetra is indicated for active immunisation against measles, mumps, rubella and varicella from 9 months of age.
protech p3 canine distemper, measles and canine parvovirus vaccine (living)
boehringer ingelheim pty limited, vetmedica division - canine distemper virus strain onderstepoort | canine parvo virus type 2 strain k3i passage 69 | measles virus strain edmonston - immunotherapy - dog - puppy - canine distemper | canine parvovirus | parvovirus
priorix powder and solvent for solution for injection. measles, mumps and rubella vaccine (live)
smithkline beecham limited - mumps vaccine rit 4385; measles virus - schwarz strain; rubella virus - wistar ra27/3 strain - powder and solvent for solution for injection - mumps vaccine rit 4385; measles virus - schwarz strain; rubella virus - wistar ra27/3 strain - vaccines
priorix-tetra
glaxosmithkline nz limited - measles vaccine, schwarz strain 1000 ccid50 (per dose); ; mumps virus, live attenuated, rit 4385 25119 ccid50 (per dose); ; ; rubella virus, wistar ra27/3 strain 1000 ccid50 (per dose); ; varicella vaccine 1995 pfu (per dose (oka strain)); - powder for injection with diluent - 0.5 ml - active: measles vaccine, schwarz strain 1000 ccid50 (per dose) mumps virus, live attenuated, rit 4385 25119 ccid50 (per dose) rubella virus, wistar ra27/3 strain 1000 ccid50 (per dose) varicella vaccine 1995 pfu (per dose (oka strain)) excipient: amino acids lactose monohydrate mannitol sorbitol water for injection - priorix-tetra is indicated for active immunisation in infants and children from the age of 9 months up to 12 years of age inclusive against measles, mumps, rubella and varicella.
m-m-r ii lyophilized powder for solution for injection (im/sc)
n/a; importer: merck sharp & dohme (i.a.) llc; distributor: merck sharp & dohme (i.a.) llc - measles, mumps and rubella vaccine (live, attenuated) - lyophilized powder for solution for injection (im/sc) - remarks: formulation: after reconstitution, each dose (0.5 ml) contains: live, attenuated virus derived from edmonston b strain of measles………………… 3.0 log tcid50* live, attenuated jeryl lynn strain of mumps…………..4.1 log tcid50* live, attenuated wistar ra27/3 strain of rubella. …………3.0 log tcid50* *tcid 50 - tissue culture infectivity dose 50%
measles rubella cipla powder
cipla medpro (pty) ltd - powder - ntl 1 000,0 ccid50 - each 0,5 ml dose contains measles virus (edmonston zagreb strain) nlt 1000,0 ccid50 rubella virus (wistar ra27/3) nlt 1 000,0 ccid50
measles rubella vaccine live
sanofi pasteur msd ltd - measles virus - schwarz strain live attenuated rubella virus (ra 27/3 strain) - solution for injection - 5 millilitre